Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SFDA Approved 434 New Drugs In 2008

This article was originally published in PharmAsia News

Executive Summary

China's State FDA accepted a total of 3,413 applications for drug registrations in 2008. The total number decreased by 75 percent and 18 percent compared to the same period in 2006 and 2007, largely because of a sharp drop in the number of applications of imitation drugs and modified drugs. SFDA approved a total of 434 new drugs for clinical applications, of which 52 are new compounds. The agency approved a total of 165 applications for new drug production, of 119 different drugs; and it approved a total of 99 applications for importation of medicines, involving 83 drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel